The present invention relates to the use of a TNF Receptor together with a steroid hormone to produce a pharmaceutical composition for the treatment of lethal bacterial and viral infections as well as autoimmune and inflammatory diseases. It also relates to said pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified treatment. In particular, it relates to the use of TBP-1 together with dehydroepiandrosterone (DHEA) or its metabolites to produce a pharmaceutical composition for the treatment of septic shock.

 
Web www.patentalert.com

< Invasive cleavage of nucleic acids

< Isolation and cultivation of microorganisms from natural environments and drug discovery based thereon

> Cyclosporins for the treatment of immune disorders

> Cyclosporins for the treatment of immune disorders

~ 00245